Valirx Plc (VAL.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 13 | -14 | -61 | -6 | 23 |
| Other Working Capital | 143 | 46 | 0 | -67 | -934 |
| Other Operating Activity | -1,741 | -1,804 | -1,652 | -1,188 | -1,000 |
| Operating Cash Flow | $-1,585 | $-1,772 | $-1,712 | $-1,261 | $-1,911 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -38 | -291 | N/A | N/A | N/A |
| Purchase Sale Intangibles | 0 | -15 | N/A | 0 | -91 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 2 |
| Investing Cash Flow | $-38 | $-306 | $N/A | $0 | $-91 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 50 |
| Debt Repayment | -10 | -10 | -13 | -5 | -80 |
| Common Stock Issued | 3,375 | 1,300 | 2,487 | 22 | 4,133 |
| Other Financing Activity | -360 | -174 | -218 | -9 | -248 |
| Financing Cash Flow | $3,004 | $1,116 | $2,256 | $7 | $3,855 |
| Beginning Cash Position | 175 | 1,137 | 594 | 1,847 | -6 |
| End Cash Position | 1,556 | 175 | 1,137 | 594 | 1,847 |
| Net Cash Flow | $1,381 | $-963 | $544 | $-1,253 | $1,853 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,585 | -1,772 | -1,712 | -1,261 | -1,911 |
| Capital Expenditure | -38 | -306 | N/A | N/A | -93 |
| Free Cash Flow | -1,623 | -2,079 | -1,712 | -1,261 | -2,004 |